0001213900-13-005605.txt : 20131008 0001213900-13-005605.hdr.sgml : 20131008 20131008092223 ACCESSION NUMBER: 0001213900-13-005605 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20131008 DATE AS OF CHANGE: 20131008 EFFECTIVENESS DATE: 20131008 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Actinium Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001388320 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 880378336 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-204170 FILM NUMBER: 131140378 BUSINESS ADDRESS: STREET 1: 501 FIFTH AVENUE, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-300-2131 MAIL ADDRESS: STREET 1: 501 FIFTH AVENUE, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: Cactus Ventures, Inc. DATE OF NAME CHANGE: 20070130 D 1 primary_doc.xml X0707 D LIVE 0001388320 Actinium Pharmaceuticals, Inc. 501 FIFTH AVENUE 3RD FLOOR NEW YORK NY NEW YORK 10017 (646)459-4201 DELAWARE None Cactus Ventures, Inc. Corporation true Kaushik J. Dave 501 Fifth Avenue 3rd Floor New York NY NEW YORK 10017 Executive Officer Director President and Chief Executive Officer Pharmaceuticals No Revenues 06b false 2013-09-25 false true true On September 25, 2013 the Company merged into itself Actinium Corporation (a 93.7% owned subsidiary). As a result of the merger, each share of Actinium Corporation not owned by the Company was exchanged for 0.333 shares of Company common stock. 0 Indefinite 0 Indefinite Shares of Actinium Corporation (fka, Actinium Pharmaceuticals, Inc.) stock, representing approximately 9.3% of the issued and outstanding shares of Actinium Corporation, were exchanged for Actinium Pharmaceuticals, Inc. stock. false 25 0 0 0 false Actinium Pharmaceuticals, Inc. /s/ Kaushik J. Dave Kaushik J. Dave President and Chief Executive Officer 2013-10-08